Clinical Case Studies Series
Patients With Chronic Diarrhea and Loose Stools
1. A Clinical Series: IBS Patients
Case series of 10 drug-refractory IBS patients who respond to oral serum-derived bovine immunoglobulin/protein isolate (SBI)
Hilal R, Mitchell P, Guerra E Jr, Burnett B.
2. A Clinical Series: IBS-D/IBS-M Patients
Serum-derived bovine immunoglobulin/protein isolate therapy for patients with refractory irritable bowel syndrome
Weinstock LB, Jasion VS.
3. A Clinical Series: IBS-D/IBS-U/IBS-M/IBS-C Patients
New therapeutic option for irritable bowel syndrome: Serum-derived bovine immunoglobulin
Good L, Rosario R, Panas R.
4. A Clinical Series: IBS-D/IBS-M Patients
Post-infectious irritable bowel syndrome with functional diarrhea following C. difficile infections: Case studies of responses using serum-derived bovine immunoglobulin
Crawford CV, Panas RM.
5. A Clinical Series: IBS Patients
Case series investigating the clinical practice experience of serum-derived bovine immunoglobulin/ protein isolate (SBI) in the clinical management of patients with inflammatory bowel disease
Good L, Panas R.
6. A Clinical Series: IBS Patients
Successful management of refractory ulcerative colitis with orally administered serum-derived bovine immunoglobulin therapy
Beauerle BD, Burnett BP, Dryden GW.
7. Retrospective Case Series: IBD Patients
Management of inflammatory bowel disease with oral serum-derived bovine immunoglobulin
Shafran I, Burgunder P, Wei D, Young HE, Klein G, Burnett BP.
8. Case Series: Chronic Colitis Patients
Use of a nutritional therapy, serum-derived bovine immunoglobulin/protein isolate (SBI), to achieve improvement in two different cases of colitis
Awad A, Jasion VS.
EnteraGam® is a medical food product intended for the dietary management of chronic diarrhea and loose stools. EnteraGam® must be administered under medical supervision.
Important Safety Information
EnteraGam® contains beef protein; therefore, patients who have an allergy to beef or any other component of EnteraGam® should not take this product. EnteraGam® has not been studied in pregnant women, in women during labor and delivery, or in nursing mothers. The choice to administer EnteraGam® during pregnancy, labor and delivery, or to nursing mothers is at the clinical discretion of the supervising physician.
EnteraGam® does not contain any milk-derived ingredients such as lactose, casein, or whey. EnteraGam® is gluten-free, dye-free, and soy-free.
Please see Full Product Information.
To report suspected adverse reactions, contact Entera Health, LLC at 1-855-4ENTERA (1-855-436-8372) or the FDA at 1-800-FDA-1088 (1-800-332-1088) or www.fda.gov/medwatch.